• Pain Management Pharmacogenetics (PGx) Gene Variation Panel
  • Protoporphyrin, Free, Blood
  • West Nile Virus (WNV) Antibody, IgG
  • Protein, Total, 24 Hour, Urine
  • Anthrax DNA by Molecular Method
  • Androgen Receptor (AR) Gene Mutation Analysis
  • Toxoplasma gondii Antibody, IgA
  • Interleukin 28 B (IL28B) Gene Variation Analysis
  • Hereditary Hemorrhagic Telangiectasia, ENG Gene Mutation Analysis
  • AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Methodology
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.